Role of the Immune Environment in Response to Therapy in Breast Cancer

ConditionsBreast Cancer ER Positive Breast Cancer HER2-negative Breast Cancer TNBC - Triple-Negative Breast Cancer

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexFemale

Age18+

SponsorAbramson Cancer Center at Penn Medicine

About this trial

This is an observational case-control study of tissues collected from women with ER+HER2- breast cancers. The immune environments of these cancers will be compared to triple negative and HER2+ breast cancers. No randomization or changes to standard of care treatment will occur as part of the study.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

Collection of personal health information from women treated at the University of Pennsylvania under an approved HIPAA waiver.

Treatment groups

No treatment groups listed

Locations

Abramson Cancer Center19104, PhiladelphiaPennsylvania, United States

Sponsors and collaborators

Abramson Cancer Center at Penn Medicine

Lead sponsor

Source ClinicalTrials.gov